Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1265]

ECHELON-2: a large peripheral T-cell lymphoma trial

Dr Owen O'Connor - Columbia University Medical Centre, New York, USA

ECHELON-2: a large peripheral T-cell lymphoma trial ( Dr Owen O'Connor - Columbia University Medical Centre, New York, USA )

ACT-1: Addition of alemtuzumab to a CHOP backbone for young patients with T...

Dr Owen O'Connor - Columbia University Medical Centre, New York, USA

ACT-1: Addition of alemtuzumab to a CHOP backbone for young patients with T-cell lymphoma ( Dr Owen O'Connor - Columbia University Medical Centre, New York, USA )

Link between gut microbiota and haematopoietic cell transplantation outcomes

Dr Jonathan Peled - Memorial Sloan Kettering Cancer Centre, New York, USA

Link between gut microbiota and haematopoietic cell transplantation outcomes ( Dr Jonathan Peled - Memorial Sloan Kettering Cancer Centre, New York, USA )

Diversity of gut microbiota linked with complications from haematopoietic cell...

Dr Jonathan Peled - Memorial Sloan Kettering Cancer Centre, New York, USA

Diversity of gut microbiota linked with complications from haematopoietic cell transplantation ( Dr Jonathan Peled - Memorial Sloan Kettering Cancer Centre, New York, USA )

Progression-free survival milestones in primary central nervous system lymphoma

Dr Jorne Lionel Biccler - Aalborg University, Aalborg, Denmark

Progression-free survival milestones in primary central nervous system lymphoma ( Dr Jorne Lionel Biccler - Aalborg University, Aalborg, Denmark )

Relapse risk and loss in expectation of lifetime in young classical hodgkin...

Dr Jorne Lionel Biccler - Aalborg University, Aalborg, Denmark

Relapse risk and loss in expectation of lifetime in young classical hodgkin lymphoma patients ( Dr Jorne Lionel Biccler - Aalborg University, Aalborg, Denmark )

Inhibiting the immune system’s natural response may boost benefits and...

Dr Shannon Maude - Children’s Hospital of Philadelphia, Philadelphia, USA

Inhibiting the immune system’s natural response may boost benefits and sustainability of CAR T therapy ( Dr Shannon Maude - Children’s Hospital of Philadelphia, Philadelphia, USA )

CD19-directed CAR T-cell therapy for patients with relapsed B-cell acute...

Dr Shannon Maude - Children’s Hospital of Philadelphia, Philadelphia, USA

CD19-directed CAR T-cell therapy for patients with relapsed B-cell acute lymphocytic leukaemia ( Dr Shannon Maude - Children’s Hospital of Philadelphia, Philadelphia, USA )

Latest results from JULIET: Tisagenlecleucel in adults with DLBCL

Dr Richard Maziarz - Oregon Health & Science Knight Cancer Institute, Portland...

Latest results from JULIET: Tisagenlecleucel in adults with DLBCL ( Dr Richard Maziarz - Oregon Health & Science Knight Cancer Institute, Portland, USA )

Luspatercept reduces need for blood transfusions in beta thalassemia and MDS

Dr Maria Domenica Cappellini - University of Milan, Milan, Italy

Luspatercept reduces need for blood transfusions in beta thalassemia and MDS ( Dr Maria Domenica Cappellini - University of Milan, Milan, Italy )

Results from the MEDALIST trial for patients with anaemia in MDS

Dr Alan List - Moffitt Cancer Center, Tampa, USA

Results from the MEDALIST trial for patients with anaemia in MDS ( Dr Alan List - Moffitt Cancer Center, Tampa, USA )

Muscle density as a predictive marker for toxicities during ovarian cancer...

Dr Lucy Dumas - The Royal Marsden NHS Foundation Trust, London, UK

Muscle density as a predictive marker for toxicities during ovarian cancer treatment ( Dr Lucy Dumas - The Royal Marsden NHS Foundation Trust, London, UK )

More from ecancer